Pre-Conference Workshop Day

Tuesday, June 13



Retinal Imaging Beyond Ophthalmology: Imaging the Optic Nerve as a Non-Invasive Approach to Detecting Neurological Disorders

In a hunt to develop less invasive biomarkers, retinal imaging has become a promising alternative for earlier identification of Alzheimer’s, Parkinson’s and Multiple Sclerosis

In this session, you will:

  • Explore how detecting retinal signatures of neurological indications could lead to faster diagnosis and more accurate patient stratification in trials
  • By visualizing neuropathological biomarkers in the optic nerve before changes occur in the brain, you will also uncover how this will enhance ability to assess treatment efficacy due to earlier intervention

Workshop leaders:

Richard Nicholas, Professor of Practice Neurology, Imperial College London
Tara DeSilva
, Associate Professor, Cleveland Clinic
Francesca Cordeiro, Professor of Glaucoma and Retinal Neurodegeneration Studies, UCL Institute of Ophthalmology


12:00 pm Lunch



Navigating the Expanding Availability of Retinal Imaging Technologies to Identify New Innovations to Transform your Clinical Pipeline

As discoveries of novel retinal imaging technologies continue to emerge into the space, ophthalmic drug developers must assess their potential to be adopted for preclinical and clinical assessments of disease activity and patient response

In this session, you will:

  • Learn how to navigate the crowded space to define good and bad imaging biomarkers for retinal therapeutic development
  • Evaluate the translatability of novel imaging modalities emerging from academic research and their ability to produce clinically useful outcomes

Workshop leaders:

Khaled Nassar, Principal Expert Retinal Health, Principal Clinical Biomarker Lead, Boehringer Ingelheim
Stephen Poor, Clinical Development Ophthalmology & Global Drug Development, Medical Lead Ophthalmology, Novartis
David Callanan, Chief Medical Officer, Aviceda Therapeutics

Ramkumar Ramamirtham, Associate Director & Optometrist, Novartis
Brijesh Yadav, Clinical & Translational Imaging Principal Scientist, Novartis